Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. - Wikidata - awgldk - TriplyDB

Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.

Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.

http://www.wikidata.org/entity/Q37245080

about

Speckle tracking echocardiography: clinical applications in cardiac resynchronization therapy.Modeling cardiac electromechanics and mechanoelectrical coupling in dyssynchronous and failing hearts: insight from adaptive computer models The "missing" link between acute hemodynamic effect and clinical response Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes.Single-beat noninvasive imaging of ventricular endocardial and epicardial activation in patients undergoing CRT A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT MR cine DENSE dyssynchrony parameters for the evaluation of heart failure: comparison with myocardial tissue tagging Electromechanical dyssynchrony and resynchronization of the failing heart Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans Systolic heart failure and cardiac resynchronization therapy: a focus on diastole Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia.Electrical remodeling in the failing heart.Remodeling of the sarcomeric cytoskeleton in cardiac ventricular myocytes during heart failure and after cardiac resynchronization therapy.Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure.Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.Patient-specific modelling of cardiac electrophysiology in heart-failure patients.The myocardial ischemia evaluated by real-time contrast echocardiography may predict the response to cardiac resynchronization therapy: a large animal study.Prognostic implications of left ventricular dyssynchrony for major adverse cardiovascular events in asymptomatic women and men: the Multi-Ethnic Study of Atherosclerosis.High resolution mapping of the cardiac transmural proteome using reverse phase protein microarrays Relationship between mechanical and electrical remodelling in patients with cardiac resynchronization implanted defibrillators.Pathobiology of cardiac dyssynchrony and resynchronization.Assessment of distribution and evolution of mechanical dyssynchrony in a porcine model of myocardial infarction by cardiovascular magnetic resonance.Glycoproteins identified from heart failure and treatment models Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart.Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure.Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure.The link between abnormal calcium handling and electrical instability in acquired long QT syndrome--Does calcium precipitate arrhythmic storms?Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction Myocyte repolarization modulates myocardial function in aging dogs Ionic bases for electrical remodeling of the canine cardiac ventricle.Mechanistic insight into prolonged electromechanical delay in dyssynchronous heart failure: a computational study Acute and Chronic Changes and Predictive Value of Tpeak-Tend for Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients Pathological ventricular remodeling: therapies: part 2 of 2.Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β.Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy

P2860

Q26801935-7E2278BC-F357-47FE-8E34-1B1CC1694F42 Q26824052-AACE31B1-D819-46B8-AAC7-4BF236BA26CD Q26824618-A7C07DD3-70F9-49A4-B826-16ABAAD30815 Q26829301-AA8DCBB1-39B3-4B38-8AEE-FB3D718DCA2E Q27312512-A5DEADED-6EA9-49A1-AF74-4B98A7BE0DE7 Q27335333-48036CA9-5EE1-4DF9-AFF8-F6E77FA98700 Q27437640-638146F4-BB89-4348-BBE2-9FE0863ACBB8 Q28714375-94DCCED0-23DB-43D7-8AB3-0C79C509A3C1 Q30417972-D97433E9-D43A-46D1-BC9D-E583D2C579E3 Q30432167-0DB7B01A-8301-43D4-8D2A-8A0FF13C9F18 Q30537534-5E0FE2FE-9616-42A9-A498-FC06BE2E0B14 Q33561264-F1900096-D6F8-4B89-90E5-AC90A081B57B Q33724430-58CCDEF0-B84B-4464-B68F-1F62A3F99F09 Q33771680-8D0F80F5-4D5F-4613-9B47-C9049594042C Q33775402-F70A453F-FB64-4AB8-9478-236B38FA4701 Q33792957-1F034825-2964-496B-A941-93C370FC7B91 Q33828985-4AB4CC05-FDE4-47EE-A46F-98BD59F4D252 Q33964797-155125AE-A807-439C-9BE3-DD529E53E06E Q34302400-B820824C-9EAC-4ECF-9E94-4D37B571C52E Q34442721-92C67EE7-4249-4180-A924-2CBE0B9BD426 Q34627316-EA325609-7644-404E-B201-B627B04F4F31 Q35026309-F307833A-5157-4AB9-AFE7-4AFD821AD676 Q35098555-B3E073B8-7143-41B3-B00C-79DCF724BB1E Q35143137-F6ACF8B7-28CA-48BD-B01A-9A167059636F Q35664494-242DC0E8-9B5F-4BE1-BB23-BD5E20DFDE31 Q35707537-3F0D73C1-1396-402A-9633-74D2CE3D45F6 Q35822160-1BD89134-E7DF-400C-8290-A95BFFAAC9DE Q35898437-6701CF9D-981E-4143-AE27-75F765C8B160 Q35898464-4A65EAD1-650A-442A-98D3-72E83733474E Q36174925-3CA472CB-BCD1-47FD-9352-B32E67F003FC Q36296695-EA4502DC-340C-4A5F-9F65-19D5A9D5BA62 Q36730574-5E1E7AB7-1058-4277-A2A8-B1DC013DA2E4 Q36773638-E0ABCCB9-96F8-411A-99C4-26CBCE2F494B Q36902443-FCAFFC1E-A8A4-440F-9774-EFE4FC60E83D Q37093711-575C7163-A524-40E0-BBCD-0E2759E3986F Q37234954-DC0C844B-8D85-4980-A5E8-9990B1E549E9 Q37255014-B06780F6-939C-4CE1-A42B-89614669879C Q37312758-4879310B-6C87-455A-BAFB-FC4A628A0705 Q37410579-87CE356E-0345-4471-922A-EE614E5E8E47 Q37692378-620F43C6-E973-4924-84CE-39F7DF282FD8

P2860

Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.

http://www.wikidata.org/entity/Q37245080

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Electrophysiological consequen ...... by resynchronization therapy.

@en

Electrophysiological consequen ...... by resynchronization therapy.

@nl

type

label

Electrophysiological consequen ...... by resynchronization therapy.

@en

Electrophysiological consequen ...... by resynchronization therapy.

@nl

prefLabel

Electrophysiological consequen ...... by resynchronization therapy.

@en

Electrophysiological consequen ...... by resynchronization therapy.

@nl

P1433

Q37245080-2765906E-185F-48D8-9E49-6621E2F1A8C9

P1476

Q37245080-29963BE9-0DE3-48E5-9C91-BFF6DD8D2A93

P2093

Q37245080-00CD5332-13A7-4916-B94A-8433F4CDCB0E

Q37245080-042F72CE-3107-49FF-B5D6-AC7CC1A8FE42

Q37245080-366EAAD8-3ACB-4F17-A1B5-F2D2D32CF006

Q37245080-39363250-1EFA-47B5-88F8-B50FA0B6D880

Q37245080-413C9924-03F9-44F5-BD88-9C7DA19439A9

Q37245080-74E671FB-7A70-4E2E-9E7E-A2E084E71B97

Q37245080-B73276F8-0790-49A0-AC69-A794D9C5C272

Q37245080-C0444D43-F019-4FDC-AA5A-165BDEB15932

Q37245080-C65F32F4-0625-4028-AE82-9B66AB76330F

Q37245080-E3EB4500-4F86-4676-AD7D-049A62C4C7C7

P2860

Q37245080-015F37A5-7429-4994-A167-133AC8BC66D5

Q37245080-0AAAC62A-9A58-427D-9EC9-E925D1857C0C

Q37245080-1A6A387A-7F20-4CEC-A74C-04DFF03E6FFD

Q37245080-20FF7DAA-8B0E-4A68-A084-D44B7278547F

Q37245080-2E4D4CC8-B113-46DC-B706-E47667CC9116

Q37245080-470D881B-2F2C-4235-AF87-226EE61E9F0C

Q37245080-49377051-F3D5-4E5F-B171-ED70AF5097D9

Q37245080-49639719-88AB-441E-BCB4-0AB9A9A88FF0

Q37245080-4A027149-30E5-4B6C-B5B1-4634BF5A914B

Q37245080-5BD85846-1ACB-49E3-83AA-FDC31781C9A3

P304

Q37245080-A6C7549B-1073-407D-8802-735436CB8B46

P31

Q37245080-B535EEEA-563F-4EC0-8A17-A97B16571CF1

P356

Q37245080-6A8FDC42-11CD-4C17-ACA0-CB46F8C6043A

P407

Q37245080-8E4F245D-DE7D-4C67-AC5C-658009264CDE

P433

Q37245080-C02D4A8C-E7ED-4978-BA45-3EE0C66BF83E

P478

Q37245080-FDE6EDE5-2D14-4997-B5F8-39634E58948E

P577

Q37245080-00D30671-572A-4551-B6CF-41838EC8D600

P698

Q37245080-21B98223-9046-40B2-BE32-93F904C49E7C

P921

Q37245080-8DF1207C-9235-400D-AE9D-7FE15B113599

Q37245080-9D619646-5E8C-4718-BD17-6B3CE55DE8C7

P932

Q37245080-2D2060D3-8794-4176-AC0D-BA7E0F5CF0AB

P356

CIRCULATIONAHA.108.794834

P1433

P1476

Electrophysiological consequen ...... by resynchronization therapy.

@en

P2093

Andreas S Barth

http://www.w3.org/2001/XMLSchema#string

Brian O'Rourke

http://www.w3.org/2001/XMLSchema#string

David A Kass

http://www.w3.org/2001/XMLSchema#string

Fadi G Akar

http://www.w3.org/2001/XMLSchema#string

Geoffrey G Hesketh

http://www.w3.org/2001/XMLSchema#string

Gordon F Tomaselli

http://www.w3.org/2001/XMLSchema#string

Khalid Chakir

http://www.w3.org/2001/XMLSchema#string

Samantapudi Daya

http://www.w3.org/2001/XMLSchema#string

Takeshi Aiba

http://www.w3.org/2001/XMLSchema#string

Theodore P Abraham

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release

Cardiac excitation-contraction coupling

Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density

Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cardiac resynchronization in chronic heart failure.

Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels

Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.

What causes sudden death in heart failure?

P304

1220-1230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.108.794834

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19237662

http://www.w3.org/2001/XMLSchema#string

P921

electrophysiology

P932

2703676

http://www.w3.org/2001/XMLSchema#string